Adam Feurstein again is the center of drama at GALE Pharmaceuticals. His articles probably are no longer effective at ARIAD, so he moved on to another up and coming biotech. Whatever you think about him, he can move mountains. It's so unbelievable that one man's pen can create havoc and affect billions of dollars, thousands of patients, and untold miseries for thousands of small investors. I hope he doesn't return here. Read for yourself.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.